Bulldog Investors’s Cartesian Growth Corp II RENE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-35,068
Closed -$402K 162
2024
Q3
$402K Sell
35,068
-7,800
-18% -$88.7K 0.14% 90
2024
Q2
$483K Buy
+42,868
New +$481K 0.18% 82
2024
Q1
Sell
-275,285
Closed -$2.99M 172
2023
Q4
$2.99M Sell
275,285
-321,216
-54% -$3.49M 0.98% 34
2023
Q3
$6.46M Buy
596,501
+35,713
+6% +$383K 2.24% 11
2023
Q2
$5.98M Buy
560,788
+25,621
+5% +$271K 1.98% 10
2023
Q1
$5.61M Buy
535,167
+111,198
+26% +$1.15M 1.8% 12
2022
Q4
$4.35M Sell
423,969
-12,314
-3% -$125K 1.31% 20
2022
Q3
$4.38M Buy
+436,283
New +$4.37M 1.28% 19

Other funds holding RENE

Bulldog Investors's RENE Position: Q4 2024 in Review

Bulldog Investors sold out of Cartesian Growth Corp II (RENE) in Q4 2024, closing a stake of 35,068 shares — an estimated $402K sold.

Bulldog Investors first reported a position in RENE in Q3 2022 and held it in 8 quarters. The position peaked at $6.46M in Q3 2023. 19 funds tracked by Wall St. Rank hold RENE as of Q4 2024.

  • Bulldog Investors reported no remaining Cartesian Growth Corp II position as of Q4 2024 after selling out during the quarter.
  • Bulldog Investors sold 35,068 Cartesian Growth Corp II shares in Q4 2024, an estimated $402K.
  • Bulldog Investors first reported a position in Cartesian Growth Corp II in Q3 2022 and held it in 8 quarters.
  • Bulldog Investors's Cartesian Growth Corp II position peaked at $6.46M in Q3 2023.
  • 19 funds tracked by Wall St. Rank held Cartesian Growth Corp II as of Q4 2024.

Based on Bulldog Investors's 13F filing for Q4 2024, filed 14 Feb 2025.